Charlesbank Capital Partners is planning a strategic review of Dallas-based MB2 Dental, which could result in the private equity firm selling its stake, according to a July 25 report by PE Hub.
Charlesbank acquired MB2 Dental in 2021 from Sentinel Capital Partners. Under Charlesbank, MB2 Dental's network has grown from 275 practices in 24 states to more than 700 practices across 42 states.
The sale of MB2 Dental could be launched by early fall. The organization is expected to be valued at between $2.3 billion and $2.5 billion.
KRR, another firm that invested in MB2 Dental alongside Charlesbank, is not expected to be a selling shareholder. MB2 Dental closed on a $2.344 billion unitranche debt facility, led by KRR, in February.
Upper mid-market to large-cap private equity firms including GTCR, PTG, Court Square and Nordic Capital could be potential buyers, the report said.
Charlesbank declined to comment and MB2 Dental did not return requests to comment from PE Hub.